166 related articles for article (PubMed ID: 24806710)
21. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
Singh RK; Kumar S; Prasad DN; Bhardwaj TR
Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
Tercel M; Lee AE; Hogg A; Anderson RF; Lee HH; Siim BG; Denny WA; Wilson WR
J Med Chem; 2001 Oct; 44(21):3511-22. PubMed ID: 11585455
[TBL] [Abstract][Full Text] [Related]
23. Chlorambucil-adducts in DNA analyzed at the oligonucleotide level using HPLC-ESI MS.
Mohamed D; Mowaka S; Thomale J; Linscheid MW
Chem Res Toxicol; 2009 Aug; 22(8):1435-46. PubMed ID: 19621941
[TBL] [Abstract][Full Text] [Related]
24. Fluoride as an inducible DNA cross-linking agent for new antitumor prodrug.
Wu J; Huang R; Wang T; Zhao X; Zhang W; Weng X; Tian T; Zhou X
Org Biomol Chem; 2013 Apr; 11(14):2365-9. PubMed ID: 23431557
[TBL] [Abstract][Full Text] [Related]
25. Highly efficient sequence-specific DNA interstrand cross-linking by pyrrole/imidazole CPI conjugates.
Bando T; Narita A; Saito I; Sugiyama H
J Am Chem Soc; 2003 Mar; 125(12):3471-85. PubMed ID: 12643709
[TBL] [Abstract][Full Text] [Related]
26. Cell cycle-dependent cytotoxicity of alkylating agents: determination of nitrogen mustard-induced DNA cross-links and their repair in Chinese hamster ovary cells synchronized by centrifugal elutriation.
Murray D; Meyn RE
Cancer Res; 1986 May; 46(5):2324-9. PubMed ID: 3697977
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.
Anderson FM; O'Hare CC; Hartley JA; Robins DJ
Anticancer Drug Des; 2000 Apr; 15(2):119-26. PubMed ID: 10901299
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.
Patterson AV; Ferry DM; Edmunds SJ; Gu Y; Singleton RS; Patel K; Pullen SM; Hicks KO; Syddall SP; Atwell GJ; Yang S; Denny WA; Wilson WR
Clin Cancer Res; 2007 Jul; 13(13):3922-32. PubMed ID: 17606726
[TBL] [Abstract][Full Text] [Related]
29. Effect of nucleosome structure on DNA interstrand cross-linking reactions.
Millard JT; Spencer RJ; Hopkins PB
Biochemistry; 1998 Apr; 37(15):5211-9. PubMed ID: 9548752
[TBL] [Abstract][Full Text] [Related]
30. Nitro reduction as an electronic switch for bioreductive drug activation.
Siim BG; Denny WA; Wilson WR
Oncol Res; 1997; 9(6-7):357-69. PubMed ID: 9406242
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.
Palmer BD; Wilson WR; Pullen SM; Denny WA
J Med Chem; 1990 Jan; 33(1):112-21. PubMed ID: 2296009
[TBL] [Abstract][Full Text] [Related]
32. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
[TBL] [Abstract][Full Text] [Related]
33. DNA cross-links in human tumor cells exposed to the prodrug PR-104A: relationships to hypoxia, bioreductive metabolism, and cytotoxicity.
Singleton RS; Guise CP; Ferry DM; Pullen SM; Dorie MJ; Brown JM; Patterson AV; Wilson WR
Cancer Res; 2009 May; 69(9):3884-91. PubMed ID: 19366798
[TBL] [Abstract][Full Text] [Related]
34. Discovery and Optimization of Novel Hydrogen Peroxide Activated Aromatic Nitrogen Mustard Derivatives as Highly Potent Anticancer Agents.
Chen W; Fan H; Balakrishnan K; Wang Y; Sun H; Fan Y; Gandhi V; Arnold LA; Peng X
J Med Chem; 2018 Oct; 61(20):9132-9145. PubMed ID: 30247905
[TBL] [Abstract][Full Text] [Related]
35. Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.
Begleiter A; Blair GW
Cancer Res; 1984 Jan; 44(1):78-82. PubMed ID: 6537800
[TBL] [Abstract][Full Text] [Related]
36. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
37. Construction of a human shuttle vector containing a single nitrogen mustard interstrand, DNA-DNA cross-link at a unique plasmid location.
Grueneberg DA; Ojwang JO; Benasutti M; Hartman S; Loechler EL
Cancer Res; 1991 May; 51(9):2268-72. PubMed ID: 2015591
[TBL] [Abstract][Full Text] [Related]
38. Preparation of Conjugated Polymer Grafted with H2O2-Sensitive Prodrug for Cell Imaging and Tumor Cell Killing.
Li M; Li S; Chen H; Hu R; Liu L; Lv F; Wang S
ACS Appl Mater Interfaces; 2016 Jan; 8(1):42-6. PubMed ID: 26713684
[TBL] [Abstract][Full Text] [Related]
39. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of DNA-protein cross-linking by antitumor nitrogen mustards.
Loeber RL; Michaelson-Richie ED; Codreanu SG; Liebler DC; Campbell CR; Tretyakova NY
Chem Res Toxicol; 2009 Jun; 22(6):1151-62. PubMed ID: 19480393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
